Update on fungal peritonitis and its treatment

Peritoneal Dialysis International

Volumn 29, Issue SUPPL. 2, 2009, Pages

  Matuszkiewicz Rowinska, Joanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Fungal peritonitis; Peritoneal catheter removal; Peritonitis prophylaxis

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE; MICAFUNGIN; NYSTATIN; POSACONAZOLE; VORICONAZOLE;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; ANTIFUNGAL SUSCEPTIBILITY; ASPERGILLUS; BACTERIAL PERITONITIS; BONE MARROW TOXICITY; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CATHETER REMOVAL; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG ERUPTION; DRUG PROTEIN BINDING; FUNGUS CULTURE; FUNGUS ISOLATION; HEMODIALYSIS; HUMAN; LIVER TOXICITY; LOADING DRUG DOSE; LONG TERM CARE; MEMBRANE DAMAGE; MORBIDITY; MORTALITY; MYCOSIS; PAECILOMYCES; PENICILLIUM; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT; ZYGOMYCETES; CANDIDA; CANDIDIASIS; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DEVICE REMOVAL; INCIDENCE; INDWELLING CATHETER; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PROGNOSIS; REVIEW;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CATHETERS, INDWELLING; DEVICE REMOVAL; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK FACTORS;

EID: 67449085315     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902902s31     Document Type: Conference Paper

References (27)

1. Warady BA, Bashir M, Donaldson LA. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int 2000; 58:384-9.
2. Chen CM, Ho MW, Yu WL, Wang JH. Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system. J Microbiol Immunol 2004; 37:115-20.
3. Greaves I, Kane K, Richards NT, Elliot TSJ, Adu D, Michel J. Pigeons and peritonitis? Nephrol Dial Transplant 1992; 86: 787-90.
4. Chou CY, Kao MT, Kuo HL, Liu JS, Liu YL, Huang CC. Gram-negative and polymicrobial peritonitis are associated with subsequent fungal peritonitis in CAPD patients. Perit Dial Int 2006; 26:607-8.
5. Raaijmakers R, Schröder C, Monnens L, Cornelissen E, Warris A. Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol 2007; 22:288-93.
6. Wang AY, Yu AW, Li PK, Lam PK, Leung CB, Lai KN, et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36: 1183-92.
7. Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 2004; 48:96-101.
8. Goldie SJ, Kiernan-Tridle L, Torres C, Gorban-Brennan N, Dunne D, Kliger AS, et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28:86-91.
9. Záruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. Am J Kidney Dis 1991; 17:43-6.
10. Robitaille P, Mérouani A, Clermónt MJ, Hébert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995; 15:77-9.
11. Wadhwa NK, Suh H, Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial 1996; 12:189-91.
12. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28:549-52.
13. Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18:583-9.
14. Williams PF, Moncrieff N, Marriott J. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20:352-3.
15. Wong PN, Lo KY, Tong GM, Chan SF, Lo MW, Mak SK, et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 2007; 27:531-6.
16. Moreiras-Plaza M, Vello-Román A, Sampróm-Rodríguez M, Feijóo-Piñeiro D. Ten years without fungal peritonitis: a single center's experience. Perit Dial Int 2007; 27:460-2.
17. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. on behalf of the ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107-31.
18. Boer WH, van Ampting JM, Vos P. Successful treatment of eight episodes of Candida peritonitis without catheter removal using intracatheter administration of amphotericin B. Perit Dial Int 2007; 27:208-10.
19. Fabris A, Pellanda MV, Gardin C, Contestabile A, Bolzonella R. Pharmacokinetics of antifungal agents. Perit Dial Int 1993; 13(Suppl 2):S380-2.
20. Kleinpeter MA. Successful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature. Adv Perit Dial 2004; 20:58-61.
21. Garbino J, Uckay I, Rohner P, Lew D, Van Delden C. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int 2005; 18:613-18.
22. Pimentel JD, Dreyer G, Lum GD. Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis. J Med Microbiol 2006; 55: 115-18.
23. Sedlacek M, Cotter JG, Suriawinata AA, Kaneko TM, Zuckerman RA, Parsonnet J, et al. Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B. Am J Kidney Dis 2008; 51:302-6.
24. Madariaga MG, Tenorio A, Proia L. Trichosporon inkin peritonitis treated with caspofungin. J Clin Microbiol 2003; 41: 5827-9.
25. Fourtounas C, Marangos M, Kalliakmani P, Savidaki E, Goumenos DS, Vlachojannis JG. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy. Nephrol Dial Transplant 2006; 21:236-7.
26. Molina P, Puchades MJ, Aparicio M, García Ramón R, Miguel A. Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases [Spanish]. Nefrologia 2005; 25:393-8.
27. Hashimoto H, Moriya R, Kamata K, Higashihara M, Yoshida K, Kume H. Successful treatment with micafungin (MCFG) of severe peritonitis due to Candida parapsilosis with chronic renal failure patient on hemodialysis [Japanese]. Kansenshogaku Zasshi 2005; 79:195-200.